Monte Rosa Therapeutics Market Sentiment

SPY767.16−0.54%QQQ737.68−0.92%BTC/USD83,896.48−0.65%DIA515.15−0.45%GLD378.66−3.75%TLT78.44−1.12%

Monte Rosa Therapeutics Inc

GLUENASDAQ

Trade with Public

$11.90

0.131.09%

Last update: Sep 28, 12:54 PM

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

Monte Rosa Therapeutics Market Sentiment

Market sentiment signals for Monte Rosa Therapeutics (GLUE): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— Overweight

Short Interest▼ 22.9% short float

Options Flow▲ 0.00 P/C ratio

Insider Activity— N/A

Analyst Consensus

Overweight

7 analysts

Options Flow (P/C)

0.00

More calls — Bullish

93 calls · 0 puts

Avg Consensus PT

$25

+111.3%

Highest Price Target

$37

+211.0%

Piper Sandler

Lowest Price Target

$11

-7.6%

JP Morgan

Short Interest

22.9%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 9, 2026	Wedbush	Robert Driscoll—	+126.9%	$27 → $27	Maintained	Outperform
Aug 25, 2026	Guggenheim	Michael Schmidt—	+135.3%	$28 → $28	Maintained	Buy
Aug 7, 2026	JP Morgan	Brian Cheng—	+126.9%	$31 → $27	Maintained	Overweight
Aug 7, 2026	Guggenheim	Michael Schmidt—	+135.3%	$35 → $28	Maintained	Buy
Aug 7, 2026	Wells Fargo	Derek Archila—	+126.9%	$29 → $27	Maintained	Overweight
Aug 3, 2026	Wedbush	Robert Driscoll—	+126.9%	$37 → $27	Maintained	Outperform
Jun 30, 2026	Guggenheim	Michael Schmidt—	+194.2%	$30 → $35	Maintained	Buy
May 11, 2026	JP Morgan	Brian Cheng—	+160.5%	$30 → $31	Maintained	Overweight
Mar 18, 2026	Guggenheim	Michael Schmidt—	+152.1%	$34 → $30	Maintained	Buy
Mar 18, 2026	Wells Fargo	Derek Archila—	+143.7%	$30 → $29	Maintained	Overweight
Jan 14, 2026	Piper Sandler	Edward Tenthoff—	+211.0%	$28 → $37	Maintained	Overweight
Jan 8, 2026	Wells Fargo	Derek Archila—	+152.1%	$22 → $30	Maintained	Overweight
Jan 8, 2026	Guggenheim	Michael Schmidt—	+185.8%	$16 → $34	Maintained	Buy
Dec 16, 2025	Wells Fargo	Derek Archila—	+84.9%	$13 → $22	Upgrade	Equal-Weight→Overweight
Nov 7, 2025	Wells Fargo	Derek Archila—	+9.3%	$10 → $13	Maintained	Equal-Weight
Mar 21, 2025	Wells Fargo	Derek Archila—	-16.0%	$11 → $10	Maintained	Equal-Weight
Mar 21, 2025	Wedbush	Robert Driscoll—	+42.9%	$15 → $17	Maintained	Outperform
Mar 12, 2025	LifeSci Capital	——	+59.7%	$19	Initiate	Outperform
Dec 19, 2024	Wells Fargo	Derek Archila—	-7.6%	$14 → $11	Downgrade	Overweight→Equal-Weight
Nov 8, 2024	Wells Fargo	Derek Archila—	+17.7%	$17 → $14	Maintained	Overweight
Sep 12, 2024	Wedbush	Robert Driscoll—	-7.6%	$11 → $11	Maintained	Outperform
Aug 12, 2024	Wells Fargo	Derek Archila—	+42.9%	$18 → $17	Maintained	Overweight
Jun 28, 2024	Piper Sandler	Edward Tenthoff—	+34.5%	$16 → $16	Maintained	Overweight
May 22, 2024	Wedbush	Robert Driscoll—	-7.6%	$11 → $11	Maintained	Outperform
Feb 15, 2024	Wedbush	Robert Driscoll—	-7.6%	$11	Initiate	Outperform